These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. [Prenatal diagnosis and carriers in families with Duchenne muscular dystrophy. The introduction of new markers]. Montejo-Pujadas Y; Zaldívar-Vaillant T; Acevedo-López AM; Guerra-Badía R Rev Neurol; 2001 Dec 1-15; 33(11):1094-5. PubMed ID: 11785038 [No Abstract] [Full Text] [Related]
63. Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements. D'Amico A; Catteruccia M; Baranello G; Politano L; Govoni A; Previtali SC; Pane M; D'Angelo MG; Bruno C; Messina S; Ricci F; Pegoraro E; Pini A; Berardinelli A; Gorni K; Battini R; Vita G; Trucco F; Scutifero M; Petillo R; D'Ambrosio P; Ardissone A; Pasanisi B; Vita G; Mongini T; Moggio M; Comi GP; Mercuri E; Bertini E Neuromuscul Disord; 2017 May; 27(5):447-451. PubMed ID: 28262469 [TBL] [Abstract][Full Text] [Related]
64. Preserving function in Duchenne dystrophy with long-term pulse prednisone therapy. Carter GT; McDonald CM Am J Phys Med Rehabil; 2000; 79(5):455-8. PubMed ID: 10994887 [TBL] [Abstract][Full Text] [Related]
65. Screening for conditions that do not meet the Wilson and Jungner criteria: the case of Duchenne muscular dystrophy. Ross LF Am J Med Genet A; 2006 Apr; 140(8):914-22. PubMed ID: 16528755 [TBL] [Abstract][Full Text] [Related]
66. EMG-based Indicators of Muscular Co-Activation during Gait in Children with Duchenne Muscular Dystrophy. Rinaldi M; Petrarca M; Romano A; Vasco G; D'Anna C; Schmid M; Castelli E; Conforto S Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():3845-3848. PubMed ID: 31946712 [TBL] [Abstract][Full Text] [Related]
67. Three-tiered noninvasive diagnosis in 96% of patients with Duchenne muscular dystrophy (DMD). Yan J; Feng J; Buzin CH; Scaringe W; Liu Q; Mendell JR; Dunnen JD; Sommer SS Hum Mutat; 2004 Feb; 23(2):203-204. PubMed ID: 14722924 [No Abstract] [Full Text] [Related]
69. Newborn screening for Duchenne muscular dystrophy gains support: researchers to push for federal recommendation to have states add DMD test to newborn panel. Levenson D Am J Med Genet A; 2012 Dec; 158A(12):viii-ix. PubMed ID: 23174945 [No Abstract] [Full Text] [Related]
70. Genetic counseling for childless women at risk for Duchenne muscular dystrophy. Eggers S; Pavanello RC; Passos-Bueno MR; Zatz M Am J Med Genet; 1999 Oct; 86(5):447-53. PubMed ID: 10508987 [TBL] [Abstract][Full Text] [Related]
71. An Opportune Time for Newborn Screening in Duchenne Muscular Dystrophy. Chrzanowski SM; McAnally MM; Kang PB JAMA Neurol; 2021 Aug; 78(8):901-902. PubMed ID: 34152378 [No Abstract] [Full Text] [Related]
76. Beware the laboratory report: discrepancy in variant classification on reproductive carrier screening. Ramdaney A; Dunn DM; Weiss RB; Rose NC Genet Med; 2018 Mar; 20(3):374-375. PubMed ID: 29261181 [No Abstract] [Full Text] [Related]
77. Can urinary titin be used for predicting Duchenne muscular dystrophy? Bai SM; Guo XX Clin Chim Acta; 2019 Mar; 490():161. PubMed ID: 30391395 [No Abstract] [Full Text] [Related]
78. Evaluation of microchip electrophoresis as a molecular diagnostic method for Duchenne muscular dystrophy. Ferrance J; Snow K; Landers JP Clin Chem; 2002 Feb; 48(2):380-3. PubMed ID: 11805028 [No Abstract] [Full Text] [Related]
79. 195th ENMC International Workshop: Newborn screening for Duchenne muscular dystrophy 14-16th December, 2012, Naarden, The Netherlands. Ellis JA; Vroom E; Muntoni F Neuromuscul Disord; 2013 Aug; 23(8):682-9. PubMed ID: 23791627 [No Abstract] [Full Text] [Related]